107 related articles for article (PubMed ID: 521060)
41. Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice.
Shiloni E; Lafreniere R; Mulé JJ; Schwarz SL; Rosenberg SA
Cancer Res; 1986 Nov; 46(11):5633-40. PubMed ID: 3489526
[TBL] [Abstract][Full Text] [Related]
42. Natural cytotoxic cells against solid tumors in mice. III. A comparison of effector cell antigenic phenotype and target cell recognition structures with those of NK cells.
Lattime EC; Pecoraro GA; Stutman O
J Immunol; 1981 May; 126(5):2011-4. PubMed ID: 7217680
[TBL] [Abstract][Full Text] [Related]
43. Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens.
Dennert G; Landon C; Lord EM; Bahler DW; Frelinger JG
J Immunol; 1988 Apr; 140(7):2472-5. PubMed ID: 3351305
[TBL] [Abstract][Full Text] [Related]
44. Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells.
Gunji Y; Gorelik E
Cancer Res; 1988 Sep; 48(18):5216-21. PubMed ID: 3409246
[TBL] [Abstract][Full Text] [Related]
45. Cell-mediated T lymphocyte responses against syngeneic cells modified with amino-reactive hapten (AED-NH2): H-2Dk serves as an element for cell-mediated lympholysis to amino-reactive hapten (AED-NH2)-modified self.
Mizuochi T; Fujiwara H; Takai Y; Hamaoka T
J Immunol; 1985 Feb; 134(2):673-6. PubMed ID: 3871213
[TBL] [Abstract][Full Text] [Related]
46. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
Pilarski LM; Carayanniotis G
J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
[TBL] [Abstract][Full Text] [Related]
47. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
48. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
Brutkiewicz RR; Klaus SJ; Welsh RM
Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
[TBL] [Abstract][Full Text] [Related]
49. Distinct phenotypic expression of immunogenicity and immunosensitivity in sublines of a tumor.
Greenberg PD; Cheever MA; Fefer A
J Immunol; 1981 Jan; 126(1):200-3. PubMed ID: 6161160
[TBL] [Abstract][Full Text] [Related]
50. Use of concanavalin A to analyse the mechanism of memory cell differentiation into killer cells.
Reme TX; Dupuy d'Angeac A; Radal M; Serrou B
Ann Immunol (Paris); 1979; 130(6):827-40. PubMed ID: 95086
[TBL] [Abstract][Full Text] [Related]
51. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
[TBL] [Abstract][Full Text] [Related]
52. Kinetic analysis of human spontaneous cell-mediated cytotoxicity.
Pollack SB; Emmons SL
J Immunol; 1979 Jul; 123(1):160-5. PubMed ID: 448145
[No Abstract] [Full Text] [Related]
53. Inhibition of macrophage-mediated cytolysis by lipoproteins from cell-free tumorous ascites.
Yamazaki M; Shinoda H; Hattori R; Mizuno D
Gan; 1977 Aug; 68(4):513-6. PubMed ID: 211066
[TBL] [Abstract][Full Text] [Related]
54. A study of the ability of H-2Kk-Iak containing subcellular fractions to elicit primary anti-H-2 cytotoxic T lymphocytes.
Hale AH; Evans DL; McGee MP
Cell Immunol; 1981 Jul; 61(2):365-74. PubMed ID: 6972812
[No Abstract] [Full Text] [Related]
55. [Immunodepressive activity of cell fractions of Escherichia coli O138:K81:H19].
Ruskova M
Vet Med Nauki; 1977; 14(9):67-71. PubMed ID: 343358
[TBL] [Abstract][Full Text] [Related]
56. Expression of inappropriate H-2 antigens on SJL reticulum cell tumors.
Roman JM; Bonavida B
Transplant Proc; 1979 Jun; 11(2):1365-6. PubMed ID: 382520
[No Abstract] [Full Text] [Related]
57. Depression of macrophage function by lipoprotein from tumorous ascites.
Takemura-Hattori R; Yamazaki M; Kurisu M; Mizuno D
Gan; 1980 Apr; 71(2):206-12. PubMed ID: 7202917
[TBL] [Abstract][Full Text] [Related]
58. Induction of the differentiation of memory T killer cells with factors released from macrophage-like cell lines.
Igarashi T; Ikeda Y; Saito H; Takano S; Kishimoto T; Shida T
Cell Immunol; 1982 Jun; 70(1):11-26. PubMed ID: 6981462
[No Abstract] [Full Text] [Related]
59. Studies of the mechanisms for the induction of in vivo tumor immunity. V. A comparison of the generation of the primary cell-mediated cytotoxic response using in vitro mixed-lymphocyte--tumor cell culture and an in vivo technique.
Rodrigues D; Ting CC
Cell Immunol; 1981 Mar; 59(1):127-37. PubMed ID: 6452224
[No Abstract] [Full Text] [Related]
60. Lipoprotein-induced inhibition of plaque-forming cell generation and natural killer cell frequency in aged donors.
Antonaci S; Jirillo E; Ventura MT; Garofalo AR; Bonomo L
Ann Immunol (Paris); 1984; 135C(2):241-9. PubMed ID: 6370094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
